COVID-19 and Cannabis as Treatment

 

 

A team of scientists recruited mild to moderate COVID-19 patients in an emergency room to investigate the safety and efficacy of Cannabidiol (CBD) as treatment.  They designed randomized, parallel-group, double-blind, placebo-controlled clinical trial in Brazil whereby patients received 300 mg of CBD or placebo added to standard symptomatic care during 14 days.  The primary result was reduction or prevention of the deterioration in clinical status from mild/moderate to severe/critical measures.

 

This is a fascinating article.  If you would like to read the full article, please review here. https://www.liebertpub.com/doi/10.1089/can.2021.0093?utm_source=Adestra&utm_medium=email&utm_term=&utm_content=ReadNow2&utm_campaign=CAN+FP+November+8+2021